Amoxicillin Dose for Mild Community-Acquired Pneumonia in Adults
For adults with mild community-acquired pneumonia, normal renal function, and no penicillin allergy, prescribe amoxicillin 1 gram three times daily (every 8 hours) for at least 7 days.
Dosing Recommendations
The most recent and authoritative guideline from the American Thoracic Society/Infectious Diseases Society of America (2019) provides clear direction for outpatient pneumonia treatment 1. For healthy adults without comorbidities or risk factors for resistant pathogens, amoxicillin 1 gram three times daily is the strong recommendation with moderate quality evidence 1.
Key Dosing Parameters:
- Standard dose: 1,000 mg every 8 hours (three times daily)
- Duration: Minimum 7 days for uncomplicated cases 2
- Administration: Take at the start of meals to minimize gastrointestinal intolerance 3
- Treatment continuation: Continue for 48-72 hours beyond symptom resolution 3
Clinical Context and Rationale
The European Respiratory Society guidelines, though older (1998), align with this dosing by recommending amoxicillin 500-1,000 mg every 8 hours for community-acquired lower respiratory tract infections 2. The higher dose (1 gram) is preferred for pneumonia specifically, as it provides better coverage against Streptococcus pneumoniae, the most common bacterial pathogen in community-acquired pneumonia.
Important distinction: The 1998 ERS guidelines show different dosing for hospitalized versus outpatient pneumonia. For hospitalized patients on medical wards, they recommend IV amoxicillin 1 gram every 6 hours 2. However, for mild pneumonia managed as an outpatient, the oral 1 gram every 8 hours regimen is appropriate.
When to Consider Alternative Regimens
Patients WITH Comorbidities:
If your patient has chronic heart, lung, liver, or renal disease; diabetes; alcoholism; malignancy; or asplenia, do not use amoxicillin monotherapy. Instead, use combination therapy 1:
- Amoxicillin-clavulanate 875/125 mg twice daily PLUS a macrolide (azithromycin or clarithromycin), OR
- Respiratory fluoroquinolone monotherapy (levofloxacin 750 mg daily or moxifloxacin 400 mg daily)
Geographic Resistance Patterns:
The 2019 ATS/IDSA guidelines note that macrolides should only be used as monotherapy in areas where pneumococcal macrolide resistance is <25% 1. This caveat doesn't apply to amoxicillin, which maintains excellent activity against S. pneumoniae even with intermediate penicillin resistance.
Duration of Therapy: Recent Updates
Recent evidence (2025) supports shorter treatment durations when patients achieve clinical stability 4:
- 3 days if clinically stable by day 3 (defined as afebrile, improved symptoms, stable vital signs)
- 5 days if stability achieved by day 5
- 7 days for other uncomplicated cases
Clinical stability criteria include: temperature ≤37.8°C, heart rate ≤100 bpm, respiratory rate ≤24/min, systolic BP ≥90 mmHg, oxygen saturation ≥90%, ability to take oral intake, and normal mental status 4.
However, the traditional 7-day minimum remains the safer, more conservative approach for most practitioners, particularly given the older guideline recommendations 2.
Renal Dosing Adjustments
For patients with severe renal impairment 3:
- GFR 10-30 mL/min: 500 mg every 12 hours
- GFR <10 mL/min: 500 mg every 24 hours
- Hemodialysis: 500 mg every 24 hours, with additional dose during and after dialysis
Critical caveat: Patients with GFR <30 mL/min should NOT receive the 875 mg formulation 3.
Common Pitfalls to Avoid
Underdosing: Do not use 500 mg three times daily for pneumonia—this is insufficient for adequate pneumococcal coverage in pneumonia, though it may be listed for other respiratory infections 2
Wrong patient selection: Amoxicillin monotherapy is only appropriate for previously healthy adults without comorbidities 1. Elderly patients (≥65 years) or those with comorbidities require broader coverage.
Premature discontinuation: Ensure treatment continues for at least 48-72 hours after clinical improvement, not just until symptoms resolve 3
Ignoring treatment failure: If no improvement occurs within 48-72 hours, reassess the diagnosis and consider broader-spectrum antibiotics or hospitalization 2
Assessment of Response
Evaluate clinical response at days 2-3 for hospitalized patients or days 5-7 for outpatients 2. Primary assessment criterion is fever resolution, though cough may persist longer. Lack of improvement warrants clinical and radiological reassessment.